Your doctor may prescribe blood tests to check if you have low sodium or potassium levels, or high calcium levels.
If you consider that any of the above situations may affect you or have any doubts about how to take this medication, consult your doctor or pharmacist.
Interaction of Indapamida retard Mabo with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any medication.
You should not take Indapamida retard Mabo with lithium (used to treat depression) due to the risk of increased lithium levels in the blood.
Make sure to inform your doctor if you are using any of the following medications, as special care may be required:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
This medication is not recommended during pregnancy. When pregnancy is planned or confirmed, the switch to an alternative treatment should be made as soon as possible.Inform your doctor if you are pregnant or plan to become pregnant.
The active ingredient is excreted in breast milk. If you are taking this medication, breastfeeding is not recommended.
Driving and operating machinery
It is unlikely that Indapamida retard Mabo will affect your ability to drive or operate machinery. However, like other medications used to treat high blood pressure, Indapamida retard Mabo may cause dizziness or drowsiness in some people. If you experience dizziness or drowsiness, consult your doctor before engaging in these activities.
Important information about one of the components of Indapamida retard Mabo
It is reported to athletes that this medication contains a component that may result in a positive analytical result for doping control.
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions provided by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Remember to take your medication.
The usual dose is one tablet per day, preferably in the mornings. Tablets can be taken with or without food.
Tablets should be swallowed whole with a glass of water and should not be chewed. Treatment for high blood pressure is lifelong.
Your doctor will inform you of the duration of your treatment with Indapamida retard Mabo.
If you take more Indapamida retard Mabo than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
A very high dose of Indapamida retard Mabo could cause nausea, vomiting, low blood pressure, muscle cramps, dizziness, drowsiness, confusion, changes in the amount of urine produced by the kidneys.
If you forget to take Indapamida retard Mabo
If you forget to take your dose of Indapamida retard Mabo, take the next dose at the usual time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Indapamida retard Mabo
Since treatment for high blood pressure is usually lifelong, you should talk to your doctor before stopping this medication.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medications, Indapamida retard Mabo may cause side effects, although not everyone will experience them.
These may include:
Feeling tired, dizziness, headache, tingling (paresthesia);
Gastrointestinal disorders (such as nausea, constipation), dry mouth;
Increased risk of dehydration in the elderly and in patients with heart failure.
Low levels of chloride in the blood.
Low levels of magnesium in the blood
Irregular heart rhythm, low blood pressure;
Renal disease;
Pancreatitis (inflammation of the pancreas that produces pain in the upper abdomen), liver function alteration. In cases of liver failure, there is a possibility of developing hepatic encephalopathy (degenerative brain disease).
Changes in blood cells, such as thrombocytopenia (decrease in the number of platelets, which favors the appearance of bruises and nasal bleeding), leucopenia (decrease in white blood cells, which may cause fever without apparent cause, sore throat, or other symptoms similar to the flu – if this occurs, contact your doctor) and anemia (decrease in red blood cells).
Angioedema and/or urticaria, severe skin manifestations. Angioedema is characterized by inflammation of the skin of the extremities or face, inflammation of the lips or tongue, inflammation of the mucous membranes of the throat or respiratory tract that causes difficulty breathing or difficulty swallowing. If this occurs, contact your doctor immediately.
If you have systemic lupus erythematosus (a type of collagen disease), it may worsen. Cases of photosensitivity reactions (change in skin appearance) have also been reported after exposure to the sun or artificial UVA rays.
Decreased vision or eye pain due to high pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal hemorrhage) or acute angle-closure glaucoma].
You may notice some changes in your laboratory tests, so your doctor may prescribe blood tests to monitor your condition. The following changes may be observed in your laboratory tests:
If you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this prospectus, inform your doctor or pharmacist.
Keep out of the reach and sight of children. No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging after
Exp. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of Indapamida retard MABO
Appearance of the product and contents of the packaging
Prolonged-release tablets, white in color, round, and biconvex.
The Indapamida Retard MABO tablets are packaged in PVC/Aluminum blisters. Each package contains 30 tablets
Holder of the marketing authorization
MABO-FARMA S.A.
Calle Rejas 2, 1st floor
28821 Coslada Madrid, Spain
Responsible for manufacturing
MEIJI PHARMA SPAIN, S.A.
Avda. de Madrid, 94,
28802, Alcalá de Henares
Madrid, Spain
This leaflet was approved in November 2021
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.